NSN 6505-01-055-5070, 6505010555070
CLONAZEPAM TABLETS

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 010555070
Codification Country: United States
Item Name Code: INC 33952
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-055-5070

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-055-5070

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-055-5070

National Stock Number (NSN) 6505-01-055-5070, or NIIN 010555070, (clonazepam tablets) was assigned February 7, 1978 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 8 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 5 suppliers. Today, 3 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 3 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Mar 01, 2020, this NSN's acquisition method was noted as: Suitable for competitive acquisition for the first time. (Potential sources shall include dealers/distributors.) This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 33952. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505010555070 does not contain precious metals.

This information was last updated on May 01, 2024.

Technical Characteristics

PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) CLONAZEPAM TABLETS USP 2 MG 100S BT
EXTERIOR CONTAINER QUANTITY: (EXQT) 144
UNIT OF ISSUE CUBE: (SUCB) 0.004 CUBIC FEET
UNIT OF ISSUE WEIGHT: (SUWT) 0.10 POUNDS
EXTERIOR CONTAINER CUBIC MEASURE: (EXME) 1.000 CUBIC FEET
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) KLONOPIN (CLONAZEPAM) 2 MG TABLET 100S
INTERMEDIATE PACKAGE QUANTITY: (PKQT) 12
EXTERIOR CONTAINER WEIGHT: (ECWT) 9.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) CLONAZEPAM TABLETS USP 2 MG 100S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 2.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) KLONOPIN (CLONAZEPAM) 2 MG TABLET 100S
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 100.000 TABLETS
PRIMARY CONTAINER TYPE: (CQCT) BOTTLE
PROTECTIVE STORAGE FEATURE: (AJCN) SECURITY STORAGE
SPECIAL FEATURES: (FEAT) EACH TABLET CONTAINS 2 MG OF CLONAZEPAM IN BOTTLES OF 100 TABLETS; STRENGTH: 2 MG; SCHEDULE IV CONTROLLED SUBSTANCE; STORE AT 20 TO 25 C (68 TO 77 F), (SEE USP CONTROLLED ROOM TEMPERATURE)